Trial intelligence / Profile preview

Letrozole vs Placebo in Primary Breast Cancer Completing Adjuvant Tamoxifen

NCT00003140Phase 3Completed

Sponsor
Canadian Cancer Trials Group
Start
Aug 1998
Primary completion
Aug 2003
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 3 trial of letrozole in breast cancer, sponsored by Canadian Cancer Trials Group. Started Aug 1998; status: completed.

02

Drugs

letrozole
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00003140.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003140.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call